Pharmabiz

Stakeholders push for stronger supply chain compliance through GSDP training

Stakeholders push for stronger supply chain compliance through GSDP training: Shardul Nautiyal, Mumbai Tuesday, June 23, 2026 ...
Pharmabiz

Antengene announces exclusive license agreement with MPM BioImpact

Antengene announces exclusive license agreement with MPM BioImpact: US, Singapore and Hong Kong Tuesday, June 23, 2026, 18:00 Hrs [IST] Antengene Corporation Limited, a leading in ...
Pharmabiz

BioArctic and Eli Lilly sign research and collaboration agreement

BioArctic AB announced that the company has entered into a research and collaboration agreement with Eli Lilly and Company regarding a potential new treatment combining BioArctic’s proprietary ...
Pharmabiz

Manappuram Foundation spotlights 'Digital Dementia', calls for greater awareness on technology's cognitive impact

Manappuram Foundation spotlights 'Digital Dementia', calls for greater awareness on technology's cognitive impact: Our Bureau, Bengaluru Tuesday, June 23, 2026, 13:50 Hrs [IST] Ma ...
Pharmabiz

Sun Pharma to acquire 100 percent stake in Innovcare Lifesciences for Rs 271.2 crore

Sun Pharma to acquire 100 percent stake in Innovcare Lifesciences for Rs 271.2 crore: Our Bureanu, Chennai Tuesday, June 23, 2026, 12:10 Hrs [IST] India’s largest drugmaker, Sun ...
Pharmabiz

Online Chikitsa Mitra expands medical store-led e-clinic network to improve healthcare access across rural India

Online Chikitsa Mitra expands medical store-led e-clinic network to improve healthcare access across rural India: Our Bureau, Bengaluru Tuesday, June 23, 2026, 13:45 Hrs [IST] Onl ...
Pharmabiz

MoonLake announces week-52 results of Sonelokimab from its Phase III Program

MoonLake announces week-52 results of Sonelokimab from its Phase III Program: Zug, Switzerland Tuesday, June 23, 2026, 16:00 Hrs [IST] MoonLake Immunotherapeutics, a clinical-stag ...
Pharmabiz

AIOCD scores win as Abbott India agrees to review disputed zero-value credit notes

AIOCD scores win as Abbott India agrees to review disputed zero-value credit notes: Peethaambaran Kunnathoor, Chennai Tuesday, June 23, 2026, 14:30 Hrs [IST] Abbott India has agre ...
Pharmabiz

Merck announces positive top line results from a Phase 3 study on tulisokibart

Merck, known as MSD outside of the United States and Canada, announced positive topline results from the Phase 3 ATLAS-UC induction-only study (Study 2) evaluating tulisokibart (MK-7240), an ...
Pharmabiz

CureGene achieves first participant dosed in US trial for antiplatelet drug Evategrel

CureGene achieves first participant dosed in US trial for antiplatelet drug Evategrel: Shanghai CureGene Pharmaceutical announced that the ...
Pharmabiz

Boehringer Ingelheim initiates three Phase III trials in hard-to-treat cancers

Boehringer Ingelheim initiates three Phase III trials in hard-to-treat cancers: Ingelheim, Germany and Ridgefield, Connecticut Tuesday, June 23, 2026, 13:00 Hrs [IST] Boehringer I ...
Pharmabiz

Edwards Lifesciences convenes RESILIA Summit 2026 across Asia Pacific in cardiac surgery

Edwards Lifesciences convenes RESILIA Summit 2026 across Asia Pacific in cardiac surgery: Our Bureau, Mumbai Tuesday, June 23, 2026, 12:30 Hrs [IST] Against this backdrop, Edwards ...